ENZYMATIC CHANGES IN THE CEREBROSPINAL-FLUID IN PATIENTS WITH INFECTIONS OF THE CENTRAL-NERVOUS-SYSTEM
ACTA PAEDIATRICA
Authors: LUTSAR, I; HALDRE, S; TOPMAN, M; TALVIK, T
Abstract
Enzymatic determinations in cerebrospinal fluid (CSF) of aspartate aminotransferase (AST), lactic dehydrogenase (LDH), gammaglutamyl transpeptidase (GGT), creatine phosphokinase (CPK) and creatine kinase BB (CK-BB) were performed in 16 patients with aseptic meningitis (AM), in 25 children with bacterial meningitis (BM) and in 15 patients with meningism. The activity of AST and GGT was significantly higher in patients with BM on admission compared with those with AM and meningism (p < 0.05 and p < 0.005, respectively) and decreased with therapy. The highest concentration of AST and LDH appeared in patients with poor outcome as well as in those with ventriculomegaly on neurosonography (p < 0.05). The concentration of CK-BB increased in all patient groups on admission and remained higher on termination of therapy. The present study confirms the high activity of AST and GGT in BM patients in the CSF whereas the increased activity of AST and LDH reflects the extent of brain injury. Nevertheless, the prognosis for individual patients cannot be established on the basis of enzyme activity alone, but depends on several factors.
Creatine kinase BB in brain in schizophrenia
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
Authors: Burbaeva, GS; Savushkina, OK; Boksha, IS
Abstract
Creatine kinase (CK) is responsible for the creatine/ creatine phosphate level, which is known to alter in tire brain of patients with schizophrenia. A comparative estimation of CK enzymatic activity and immunoreactivity of CK BB was carried out in readily soluble extracts from frontal cortex, anterior and posterior cingulate cortex, hippocampus and cerebellum from brains of individuals with schizophrenia versus normal controls. CK activity was determined rising a commercial diagnostic kit. CK BB immunoreactivity was evaluated by ECL-immunoblotting using monoclonal antibody. A drastic drop of CK activity and CK BB immunoreactivity was observed in all the examined brain areas in schizophrenic patients compared to controls (p<0.01), with the maximum drop in the cerebellum. The reduction was independent of age, postmortem interval or chlorpromazine equivalent. The decreased level of CK BB in schizophrenia was confirmed by purification of CK BB from brains of patients with schizophrenia and control brains: the yield or the purified enzyme was significantly lower in schizophrenia, wherein molecular masses or CK B-subunits were equal. Possible causes and consequences of the decrease in CK BB level observed in brain of patients with schizophrenia are discussed.